FLULAVAL 2025/2026 15 ug/.5mL
influenza virus vaccine · SUSPENSION · ID Biomedical Corporation of Quebec
No Recall History
Plain English
FLULAVAL 2025/2026 is a suspension containing influenza virus vaccine at 15 ug/.5mL, taken intramuscular. Manufactured by ID Biomedical Corporation of Quebec.
Key Facts
- Brand Name
- FLULAVAL 2025/2026
- Generic Name
- influenza virus vaccine
- NDC Code (Product)
19515-904- Manufacturer
- ID Biomedical Corporation of Quebec
- Strength
- 15 ug/.5mL
- Dosage Form
- SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125163
- Marketing Start
- 07/01/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is FLULAVAL 2025/2026 used for?
FLULAVAL 2025/2026 contains influenza virus vaccine. It is a suspension taken intramuscular. Consult your doctor for specific uses.
Is FLULAVAL 2025/2026 a controlled substance?
FLULAVAL 2025/2026 is not classified as a controlled substance by the DEA.
What is the generic name for FLULAVAL 2025/2026?
The generic name for FLULAVAL 2025/2026 is influenza virus vaccine. There are 1 other brand versions of influenza virus vaccine.
What is the NDC code for FLULAVAL 2025/2026 15 ug/.5mL?
The NDC (National Drug Code) for FLULAVAL 2025/2026 15 ug/.5mL is 19515-904, listed by ID Biomedical Corporation of Quebec.